News
TTNP
3.420
-0.63%
-0.022
Weekly Report: what happened at TTNP last week (1202-1206)?
Weekly Report · 4d ago
Titan Pharmaceuticals Appoints Chay Weei Jye as CEO
TipRanks · 12/06 21:58
TITAN PHARMACEUTICALS: ON DEC 2 COMPANY APPOINTED CHAY WEEI JYE AS THE CO'S CEO
Reuters · 12/06 21:33
Weekly Report: what happened at TTNP last week (1125-1129)?
Weekly Report · 12/02 10:54
Titan Pharmaceuticals Faces Nasdaq Compliance Challenges with Reporting and Audit Committee Requirements
Barchart · 11/28 01:20
Titan Pharmaceuticals announces non-compliance notice from Nasdaq
Seeking Alpha · 11/27 21:22
Titan Pharmaceuticals receives Nasdaq notice of non-compliance
TipRanks · 11/27 21:10
Titan Pharmaceuticals Gets Non-Compliance Notice From Nasdaq
Benzinga · 11/27 21:08
TITAN PHARMACEUTICALS, INC. ANNOUNCES RECEIPT OF NOTICE FROM NASDAQ
Reuters · 11/27 21:05
Weekly Report: what happened at TTNP last week (1118-1122)?
Weekly Report · 11/25 10:48
Weekly Report: what happened at TTNP last week (1111-1115)?
Weekly Report · 11/18 10:45
Weekly Report: what happened at TTNP last week (1104-1108)?
Weekly Report · 11/11 10:56
TITAN PHARMACEUTICALS- APPOINTS BRYNNER CHIAM AS ACTING PRINCIPAL EXECUTIVE OFFICER & ACTING PRINCIPAL FINANCIAL OFFICER OF CO
Reuters · 11/08 21:14
Weekly Report: what happened at TTNP last week (1028-1101)?
Weekly Report · 11/04 10:54
Weekly Report: what happened at TTNP last week (1021-1025)?
Weekly Report · 10/28 10:47
BUZZ-U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Reuters · 10/24 18:29
BUZZ-Titan Pharma falls as CEO announces resignation
Reuters · 10/24 16:13
TITAN PHARMACEUTICALS: SEOW GIM SHEN TO RESIGN AS CHAIRMAN & CEO
Reuters · 10/24 13:19
Weekly Report: what happened at TTNP last week (1014-1018)?
Weekly Report · 10/21 10:45
Weekly Report: what happened at TTNP last week (1007-1011)?
Weekly Report · 10/14 11:07
More
Webull provides a variety of real-time TTNP stock news. You can receive the latest news about Titan Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About TTNP
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.